logo
Cardiovascular Surgery News
Scientific and Information Journal




a:2:{s:4:"TEXT";s:75:"Heparin- induced thrombocytopenia: the review of clinical recom- mendations";s:4:"TYPE";s:4:"HTML";}


Authors: Kupryashov А.А., Khicheva G.А. (compilers)

E-mail: Сведения доступны для зарегистрированных пользователей.

Heading: Clinical guidelines

UDC: 616.155.294(048.8)

Link: Clinical Physiology of Blood Circulaiton. 2018; 2 (2): 102-111

Quote as: Kupryashov A.A., Khicheva G.A. (compilers) Heparin-induced thrombocytopenia: the review of clinical recommenda- tions. Cardiovascular Surgery News. 2018; 2 (2): 102–11 (in Russ.). DOI: 10.24183/2588-0284-2018-2-2-102-111

Received / Accepted:  May 11, 2018 / May 17, 2018

Full text:  


Abstract

We present the review of clinical guidelines of American College of Chest Physicians (ACCP) on prognostication, diagnosis, treatment and prevention of heparin-induced thrombocytopenia. The classification of the quality of evidence and grade strength of recommendations is given, as well as the results of their critical appraisal in comparison with other existing guidelines with the help of Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument.

References

  1. Linkins L.A., Dans A.L., Moores L.K., Bona R., Davidson B.L., Schulman S., Crowther M. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl.): e495S–530S. DOI: 10.1378/chest.11-2303

  2. Wang Y., Ye Z.K., Li J.F., Cui X.L., Liu L.H. Heparin-induced thrombocytopenia: a critical appraisal of clinical practice guidelines with the AGREE II instrument. Thromb Res. 2018; 166: 10–8. DOI: 10.1016/j.thromres.2018.03.01


© Bakoulev National Medical Research Center for Cardiovascular Surgery,
Ministry of Health of the Russian Federation

Privacy Policy (in Russian)

Produced by
Bakoulev CCVS IT Departament